DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Concerta (Methylphenidate Hydrochloride) - Published Studies

 
 



Concerta Related Published Studies

Well-designed clinical trials related to Concerta (Methylphenidate)

Ameliorating attention problems in children with sickle cell disease: a pilot study of methylphenidate. [2012]

Methylphenidate treatment of adult male prison inmates with attention-deficit hyperactivity disorder: randomised double-blind placebo-controlled trial with open-label extension. [2012]

Is response to OROS-methylphenidate treatment moderated by treatment with antidepressants or psychiatric comorbidity? A secondary analysis from a large randomized double blind study of adults with ADHD. [2012]

Efficacy of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder previously treated with methylphenidate: a post hoc analysis. [2011.11.04]

Comparison of the Efficacy of Two Different Modified Release Methylphenidate Preparations for Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a Natural Setting: Comparison of the Efficacy of Medikinet((R)) Retard and Concerta((R))-a Randomized, Controlled, Double-Blind Multicenter Clinical Crossover Trial. [2011.10]

Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders. [2011.09]

Effect of osmotic-release oral system methylphenidate on different domains of attention and executive functioning in children with attention-deficit-hyperactivity disorder. [2011.09]

Are stimulants effective in the treatment of executive function deficits? Results from a randomized double blind study of OROS-methylphenidate in adults with ADHD. [2011.07]

Pharmacokinetics and therapeutic effect of OROS methylphenidate under different breakfast conditions in children with attention-deficit/hyperactivity disorder. [2011.06]

Atomoxetine and methylphenidate treatment in children with ADHD: the efficacy, tolerability and effects on executive functions. [2011.06]

Methylphenidate but not atomoxetine or citalopram modulates inhibitory control and response time variability. [2011.05.01]

A randomized, single-blind, substitution study of OROS methylphenidate (Concerta) in ADHD adults receiving immediate release methylphenidate. [2011.05]

Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trial. [2011.04.05]

Academic, behavioral, and cognitive effects of OROS(R) methylphenidate on older children with attention-deficit/hyperactivity disorder. [2011.04]

Effects of OROS methylphenidate on academic, behavioral, and cognitive tasks in children 9 to 12 years of age with attention-deficit/hyperactivity disorder. [2011.04]

Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysis. [2011.02.01]

Long-term safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: an open-label, dose-titration, 1-year study. [2011.02]

Methylphenidate for treating tobacco dependence in non-attention deficit hyperactivity disorder smokers: a pilot randomized placebo-controlled trial. [2011.01.28]

Methylphenidate increases choice of cigarettes over money. [2011.01]

Effect of methylphenidate and/or levodopa combined with physiotherapy on mood and cognition after stroke: a randomized, double-blind, placebo-controlled trial. [2011]

Dose effects and comparative effectiveness of extended release dexmethylphenidate and mixed amphetamine salts. [2011]

Gender differences in the effects of methylphenidate on energy intake in young adults: a preliminary study. [2011]

An exploration of site effects in a multisite trial of OROS-methylphenidate for smokers with attention deficit/hyperactivity disorder. [2011]

Methylphenidate normalizes frontocingulate underactivation during error processing in attention-deficit/hyperactivity disorder. [2011]

Effect of osmotic-release oral system methylphenidate on different domains of attention and executive functioning in children with attention-deficit-hyperactivity disorder. [2011]

Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trial. [2011]

Effects of OROS methylphenidate on academic, behavioral, and cognitive tasks in children 9 to 12 years of age with attention-deficit/hyperactivity disorder. [2011]

Long-term safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: an open-label, dose-titration, 1-year study. [2011]

Methylphenidate transdermal system in adult ADHD and impact on emotional and oppositional symptoms. [2011]

A one year trial of methylphenidate in the treatment of ADHD. [2011]

Multiscale assessment of treatment efficacy in adults with ADHD: A randomized placebo-controlled, multi-centre study with extended-release methylphenidate. [2010.12.14]

Amantadine versus methylphenidate in children and adolescents with attention deficit/hyperactivity disorder: a randomized, double-blind trial. [2010.12.08]

Methylphenidate for fatigue in ambulatory men with prostate cancer. [2010.11.01]

A randomized, rater-blinded, crossover study comparing the clinical efficacy of Ritalin((R)) LA (methylphenidate) treatment in children with attention-deficit hyperactivity disorder under different breakfast conditions over 2 weeks. [2010.11]

Amantadine versus methylphenidate in children and adolescents with attention deficit/hyperactivity disorder: a randomized, double-blind trial. [2010.11]

Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial. [2010.11]

A randomized, 3-phase, 34-week, double-blind, long-term efficacy study of osmotic-release oral system-methylphenidate in adults with attention-deficit/hyperactivity disorder. [2010.10]

Time course and predictors of health-related quality of life improvement and medication satisfaction in children diagnosed with attention-deficit/hyperactivity disorder treated with the methylphenidate transdermal system. [2010.10]

Single- and multiple-dose pharmacokinetics of methylphenidate administered as methylphenidate transdermal system or osmotic-release oral system methylphenidate to children and adolescents with attention deficit hyperactivity disorder. [2010.10]

Methylphenidate significantly improves declarative memory functioning of adults with ADHD. [2010.10]

The single-dose pharmacokinetics of NWP06, a novel extended-release methylphenidate oral suspension. [2010.09]

Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial. [2010.08.10]

OROS methylphenidate in the treatment of adults with ADHD: a 6-month, open-label, follow-up study. [2010.08]

Testing Tic suppression: comparing the effects of dexmethylphenidate to no medication in children and adolescents with attention-deficit/hyperactivity disorder and Tourette's disorder. [2010.08]

OROS-methylphenidate or placebo for adult smokers with attention deficit hyperactivity disorder: racial/ethnic differences. [2010.07.01]

Adaptive phase I study of OROS methylphenidate treatment of attention deficit hyperactivity disorder with epilepsy. [2010.07]

Non-specific effects of methylphenidate (Ritalin) on cognitive ability and decision-making of ADHD and healthy adults. [2010.07]

Effect of methylphenidate and/or levodopa coupled with physiotherapy on functional and motor recovery after stroke - a randomized, double-blind, placebo-controlled trial. [2010.06.21]

Dose-response characteristics in adolescents with attention-deficit/hyperactivity disorder treated with OROS methylphenidate in a 4-week, open-label, dose-titration study. [2010.06]

Sex differences in attentional performance and their modulation by methylphenidate in children with attention-deficit/hyperactivity disorder. [2010.06]

A controlled trial of the methylphenidate transdermal system on before-school functioning in children with attention-deficit/hyperactivity disorder. [2010.05]

Clinical response to methylphenidate in children diagnosed with attention-deficit hyperactivity disorder and comorbid psychiatric disorders. [2010.05]

Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. [2010.04.01]

Predicting methylphenidate response in long-term survivors of childhood cancer: a randomized, double-blind, placebo-controlled, crossover trial. [2010.03]

A PET study examining pharmacokinetics and dopamine transporter occupancy of two long-acting formulations of methylphenidate in adults. [2010.02]

A One Year Trial of Methylphenidate in the Treatment of ADHD. [2010.01.13]

A randomized, 3-phase, 34-week, double-blind, long-term efficacy study of osmotic-release oral system-methylphenidate in adults with attention-deficit/hyperactivity disorder. [2010]

Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial. [2010]

Buspirone versus methylphenidate in the treatment of attention deficit hyperactivity disorder: a double-blind and randomized trial. [2010]

Adaptive phase I study of OROS methylphenidate treatment of attention deficit hyperactivity disorder with epilepsy. [2010]

Clinical response to methylphenidate in children diagnosed with attention-deficit hyperactivity disorder and comorbid psychiatric disorders. [2010]

Personality disorders in ADHD Part 2: The effect of symptoms of personality disorder on response to treatment with OROS methylphenidate in adults with ADHD. [2010]

Personality disorder in ADHD Part 1: Assessment of personality disorder in adult ADHD using data from a clinical trial of OROS methylphenidate. [2010]

Methylphenidate enhances prepulse inhibition during processing of task-relevant stimuli in attention-deficit/hyperactivity disorder. [2010]

Lack of bioequivalence between two methylphenidate extended modified release formulations in healthy volunteers. [2009.12]

HRQL and medication satisfaction in children with ADHD treated with the methylphenidate transdermal system. [2009.12]

Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naive children with ADHD during a rewarded continuous performance task. [2009.12]

Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial. [2009.11]

Effects of methylphenidate on discounting of delayed rewards in attention deficit/hyperactivity disorder. [2009.10]

Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder: a randomized crossover trial. [2009.10]

Effects of clonidine and methylphenidate on family quality of life in attention-deficit/hyperactivity disorder. [2009.10]

Stimulant treatment reduces lapses in attention among children with ADHD: the effects of methylphenidate on intra-individual response time distributions. [2009.08]

Efficacy and safety of dexmethylphenidate extended-release capsules administered once daily to children with attention-deficit/hyperactivity disorder. [2009.08]

Randomized, placebo-controlled, crossover study of methylphenidate for attention-deficit/hyperactivity disorder symptoms in preschoolers with developmental disorders. [2009.08]

Side effects of methylphenidate in childhood cancer survivors: a randomized placebo-controlled trial. [2009.07]

Behavioral response to methylphenidate challenge: influence of early life parental care. [2009.07]

Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study. [2009.06]

Safety of methylphenidate following traumatic brain injury: impact on vital signs and side-effects during inpatient rehabilitation. [2009.06]

Effects of application to two different skin sites on the pharmacokinetics of transdermal methylphenidate in pediatric patients with attention-deficit/hyperactivity disorder. [2009.06]

Cytogenetic assessment of methylphenidate treatment in pediatric patients treated for attention deficit hyperactivity disorder. [2009.06]

Predicting Methylphenidate Response in Long-Term Survivors of Childhood Cancer: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial. [2009.05.22]

The effect of methylphenidate on postural stability under single and dual task conditions in children with attention deficit hyperactivity disorder - a double blind randomized control trial. [2009.05.15]

Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment. [2009.05]

Reinforcing and subjective effects of methylphenidate in adults with and without attention deficit hyperactivity disorder (ADHD). [2009.05]

Efficacy of methylphenidate in the rehabilitation of attention following traumatic brain injury: a randomised, crossover, double blind, placebo controlled inpatient trial. [2009.05]

Association between homozygosity of a G allele of the alpha-2a-adrenergic receptor gene and methylphenidate response in Korean children and adolescents with attention-deficit/hyperactivity disorder. [2009.04.01]

Methylphenidate restores link between stop-signal sensory impact and successful stopping in adults with attention-deficit/hyperactivity disorder. [2009.04.01]

Dopamine-related genotypes and the dose-response effect of methylphenidate on eating in attention-deficit/hyperactivity disorder youths. [2009.04]

Methylphenidate extended release (OROS MPH) for the treatment of antidepressant-related sexual dysfunction in patients with treatment-resistant depression: results from a 4-week, double-blind, placebo-controlled trial. [2009.03]

Long-term effectiveness and safety of dexmethylphenidate extended-release capsules in adult ADHD. [2009.03]

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder. [2009.03]

Changes in psychomotor effects of L-dopa and methylphenidate after sustained dopaminergic therapy in Parkinson's disease. [2009.03]

Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity. [2009.03]

Single dose of methylphenidate improves cognitive performance in multiple sclerosis patients with impaired attention process. [2009.01.15]

Association Between Homozygosity of a G Allele of the Alpha-2a-Adrenergic Receptor Gene and Methylphenidate Response in Korean Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. [2009.01.14]

Methylphenidate improves response inhibition but not reflection-impulsivity in children with attention deficit hyperactivity disorder (ADHD). [2009.01]

Reboxetine versus methylphenidate in treatment of children and adolescents with attention deficit-hyperactivity disorder. [2009.01]

Efficacy of methylphenidate in the rehabilitation of attention following traumatic brain injury: A randomized, crossover, double-blind, placebo controlled inpatient trial. [2008.12.05]

Efficacy of osmotic-release oral system (OROS) methylphenidate for mothers with attention-deficit/hyperactivity disorder (ADHD): preliminary report of effects on ADHD symptoms and parenting. [2008.12]

Methylphenidate and amphetamine do not induce cytogenetic damage in lymphocytes of children with ADHD. [2008.12]

A pharmacokinetic study of two modified-release methylphenidate formulations under different food conditions in healthy volunteers. [2008.09]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014